Icecure Medical Ltd.
A medical device maker in Israel that freezes tumors instead of cutting them out. Its ProSense system uses a thin probe to pump liquid nitrogen into breast tumors, forming an "ice ball" that destroys the tissue, which the body later reabsorbs — all done in a doctor's office. Founded in 2006 as Arbel Medical, the company renamed itself IceCure, a nod to its icy treatment, and lives by the motto "freezing cancer, not their lives."
This item is not being amended by this Schedule 13D/A.
This item is not being amended by this Schedule 13D/A.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 13GPassive | 9.99% | 300.3K | Aug 14, 2026 |
| Steven Boyd | 13GPassive | 9.99% | 300.3K | Aug 14, 2026 |
| Mr. Li Haixiang | 13D/AActivist | 45.8% | 35.85M | Mar 27, 2026 |
This item is not being amended by this Schedule 13D/A. | ||||
| Epoch Partner Investments Limited | 13D/AActivist | 45.8% | 35.85M | Mar 27, 2026 |
This item is not being amended by this Schedule 13D/A. | ||||